Source: Annual Congress 2008 - Pulmonary mechanics and gas exchange
Disease area: Interstitial lung diseases, Pulmonary vascular diseases



Rating:

Share or cite this content

Citations should be made in the following way:
L. Stervinou, T. Perez, V. Debroucker, R. Neviere, B. Wallaert (Lille, France). Diffusing capacity for nitric oxide and capillary blood volume in patients with idiopathic interstitial pneumonia. Eur Respir J 2008; 32: Suppl. 52, 733

Member's Comments

No comment yet.

Related content which might interest you: Diffusing capacity for nitric oxide and carbon monoxide in patients with diffuse parenchymal lung disease and pulmonary arterial hypertension Source: Eur Respir J 2005; 26: Suppl. 49, 268s Year: 2005 Exhaled nitric oxide in cystic fibrosis: relationships with airway and lung vascular impairments Source: Eur Respir J 2009; 34: 117-124 Year: 2009 Diffusing capacity of the lung for nitric oxide and carbon monoxide: Influence of alveolar volume Source: Annual Congress 2010 - Advances in lung function I Year: 2010 Evaluation of exhaled nitric oxide in idiopathic interstitial lung diseases Source: International Congress 2015 – IIPs: orphan Year: 2015 Exhaled nitric oxide in patients with idiopathic pulmonary fibrosis and pulmonary hypertension Source: Annual Congress 2008 - Management of idiopathic pulmonary fibrosis: what can we learn from the pathophysiology? Year: 2008 Standardization of pulmonary diffusing capacity for nitric oxide Source: International Congress 2017 – ERS statements and technical standards on diagnosis and monitoring Year: 2017 Bronchial blood flow is normal in COPD patients and is positevily correlated with exhaled nitric oxide and the diffusion of carbon monoxide Source: Eur Respir J 2006; 28: Suppl. 50, 652s Year: 2006 Exhaled nitric oxide in chronic obstructive pulmonary disease: relationship to pulmonary function Source: Eur Respir J 2001; 17: 934-938 Year: 2001 A small amount of inhaled nitric oxide does not increase lung diffusing capacity Source: Eur Respir J 2006; 27: 1251-1257 Year: 2006 Reference equations for pulmonary diffusing capacity of carbon monoxide and nitric oxide in adult Caucasians Source: Eur Respir J, 52 (1) 1500677; 10.1183/13993003.00677-2015 Year: 2018 Exhaled nitric oxide in idiopathic and non-idiopathic interstitial lung disease Source: International Congress 2017 – ILDs: clinical problems Year: 2017 Lung diffusing capacity for nitric oxide and carbon monoxide: methodological issues and reproducibility in patients with cystic fibrosis Source: Eur Respir J 2007; 30: Suppl. 51, 325s Year: 2007 Intra-session and inter-session variability of nitric oxide pulmonary diffusing capacity in patients with cystic fibrosis Source: International Congress 2017 – Discussion of techniques and technologies in lung function Year: 2017 Fractional exhaled nitric oxide in patients with chronic obstructive pulmonary disease Source: International Congress 2019 – FeNO in airway diseases and asthma-COPD overlap identification Year: 2019 The nitric oxide diffusing capacity strongly depends on alveolar volume Source: Eur Respir J 2005; 26: Suppl. 49, 262s Year: 2005 Nitric oxide production by the alveolar compartment of the lungs in cirrhotic patients Source: Eur Respir J 2009; 34: 138-144 Year: 2009 Severity of scleroderma lung disease is related to alveolar concentration of nitric oxide Source: Eur Respir J 2007; 30: 26-30 Year: 2007 Combined measurement of carbon monoxide and nitric oxide lung transfer does not improve the identification of pulmonary hypertension in systemic sclerosis Source: Eur Respir J, 50 (4) 1701008; 10.1183/13993003.01008-2017 Year: 2017 Effect of inhaled L-arginine on airway nitric oxide in cystic fibrosis patients Source: Annual Congress 2005 - Cystic fibrosis lung disease: pieces of the puzzle Year: 2005 Profiling nitric oxide metabolites in patients with idiopathic pulmonary arterial hypertension Source: Eur Respir J 2016; 48: 1386-1395 Year: 2016